Page 2 - Marker Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent. The cardiac marker testing market includes major Tier I and II suppliers like Roche Diagnostics Ltd. (Switzerland), Abbott Laboratorie...

Cardiac Marker Testing Market worth $5.5 billion by 2025 - Exclusive Report by MarketsandMarkets "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecasts to 2025", published by MarketsandMarkets, the market is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9%. Browse in-depth TOC on "Cardiac Marker Testing Market" 102 - Tables Download PDF Brochure:...

Press release content from Business Wire. The AP news staff was not involved in its creation. $450+ Million Herpes Marker Testing Market - Global Trajectory & Analytics to 2027 - ResearchAndMarkets.com January 19, 2021 GMT DUBLIN--(BUSINESS WIRE)--Jan 19, 2021-- Global Herpes Marker Testing Market to Reach $452.8 Million by 2027 Amid the COVID-19 crisis, the global market for Herpes Marker Testing estimated at US$328.6 Million in the year 2020, is projected to reach a revised size of US$452.8 Million by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. ADVERTISEMENT Viral Cu...